21 commercial payer policies list J1951. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
21 policies from 12 payers
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
Codes labeled “Inferred from policy title” are not listed in the policy document; Backwork attached them because the policy title names the drug.
| Policy | Effective | Status of J1951 |
|---|---|---|
| Leuprolide Acetate (Fensolvi, Lupron Depot- PED, Lupron Depot) | Dec 1, 2022 | Prior auth requiredInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Leuprolide Acetate (Fensolvi, Lupron Depot- PED, Lupron Depot) | Jan 1, 2022 | Prior auth requiredInferred from policy title |
| Leuprolide Acetate (Fensolvi, Lupron Depot- PED, Lupron Depot) | Feb 1, 2021 | Prior auth requiredInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
|---|
| Leuprolide acetate (Fensolvi, Lupron Depot-PED, Lupron Depot) Non-oncology | Nov 1, 2025 | Prior auth requiredInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
|---|
| Leuprolide acetate (Fensolvi, Lupron Depot-PED, Lupron Depot) Non-oncology | Nov 1, 2024 | Prior auth requiredInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
|---|
| Leuprolide acetate (Fensolvi, Lupron Depot-PED, Lupron Depot)_Non-onc | Nov 1, 2023 | Prior auth requiredInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
|---|
| Leuprolide acetate (Fensolvi, Lupron Depot-PED, Lupron Depot)_Non-onc | Nov 1, 2024 | Prior auth requiredInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
|---|
| Leuprolide Acetate (Fensolvi) | Sep 1, 2020 | Prior auth requiredInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
|---|
| Policy | Effective | Status of J1951 |
|---|---|---|
| Leuprolide (Camcevi, Camcevi ETM, Eligard, Fensolvi, Lupron Depot) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Leuprolide (Camcevi, Camcevi ETM, Eligard, Fensolvi, Lupron Depot) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J1951 |
|---|---|---|
| Leuprolide (Camcevi, Camcevi ETM, Eligard, Fensolvi, Lupron Depot) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Leuprolide (Camcevi, Camcevi ETM, Eligard, Fensolvi, Lupron Depot) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J1951 |
|---|---|---|
| Leuprolide Acetate (e.g., Lupron Depot; Fensolvi) for Non-Oncologic Indications | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J1951 |
|---|---|---|
| Gonadotropin-Releasing Hormone (GnRH) Agonists and Antagonists | Aug 15, 2025 | Covered |
| Policy | Effective | Status of J1951 |
|---|---|---|
| Gonadotropin-Releasing Hormone (GnRH) Agonists and Antagonists | Aug 15, 2025 | Covered |
| Policy | Effective | Status of J1951 |
|---|---|---|
| Gonadotropin-Releasing Hormone (GnRH) Agonists and Antagonists | Aug 15, 2025 | Covered |
| Policy | Effective | Status of J1951 |
|---|---|---|
| Gonadotropin-Releasing Hormone (GnRH) Agonists and Antagonists | Aug 15, 2025 | Covered |
| Policy | Effective | Status of J1951 |
|---|---|---|
| Leuprolide Acetate (Eligard, Fensolvi, Lupron Depot, Lupron Depot-Ped), Leuprolide mesylate (Camcevi); CP.PCH.53. | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J1951 |
|---|---|---|
| Gonadotropin Releasing Hormone Analogs | Jul 1, 2025 | Covered |
| Policy | Effective | Status of J1951 |
|---|---|---|
| Gonadotropin Releasing Hormone Analogs | Jul 1, 2025 | Covered |
| Policy | Effective | Status of J1951 |
|---|---|---|
| Gonadotropin Releasing Hormone Analogs | Jul 1, 2025 | Covered |